lunes, 16 de junio de 2025

FDA approval of pembrolizumab marks major shift in head and neck cancer treatment

https://www.news-medical.net/news/20250615/FDA-approval-of-pembrolizumab-marks-major-shift-in-head-and-neck-cancer-treatment.aspx

No hay comentarios:

Publicar un comentario